Coca-Cola Amatil withdraws earnings guidance

The double whammy of the bushfire crisis and now the ongoing Covid-19 outbreak has forced Coca-Cola Amatil (ASX: CCL) to withdraw its earnings guidance.

In a statement posted to the ASX CCL says measures taken by governments to slow the rate of coronavirus infection have had a "myriad of consequences" on the business.

"We will continue to support our customers and our local communities, and at this stage we expect we can continue to operate our business and avoid significant supply chain disruption, while maintaining our workforce during this challenging time," says CCL managing director Alison Watkins.

In Australia and New Zealand the company says it is witnessing strong growth in its supermarket channel as customers stock up for self-isolation or quarantine periods.

Despite growth in its supermarkets channel, CCL has witnessed declines in its On-The-Go (OTG) channel.

"We would expect OTG weakness to accelerate given consumers' likely preference for staying at home as well as the widespread cancellation of major sporting, entertainment and cultural events," says CCL.

Updated at 11:22am AEDT on 17 March 2020.


Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Crypto staking: a new way to earn passive income
Partner Content
You may be familiar with traditional ways of earning passive income such as trading sto...
Etoro
Advertisement

Related Stories

Two Melbourne-made COVID-19 vaccines to launch Phase 1 trials

Two Melbourne-made COVID-19 vaccines to launch Phase 1 trials

Two COVID-19 vaccine candidates created by the Peter Doherty Instit...

WA to ease COVID restrictions as ICU numbers remain lower than predicted

WA to ease COVID restrictions as ICU numbers remain lower than predicted

The Western Australian government will ease its Level 2 restriction...

100 million doses per year: Moderna to construct mRNA manufacturing facility in Melbourne

100 million doses per year: Moderna to construct mRNA manufacturing facility in Melbourne

Up to 100 million Australian-made mRNA vaccines will be produced in...

“We’re ready to welcome the world back”: NZ reopening to vaccinated Aussies on 12 April

“We’re ready to welcome the world back”: NZ reopening to vaccinated Aussies on 12 April

Australian tourists will be welcomed into New Zealand without havin...